1. Lassmann H, Brück W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med. 2001; 7:115–121. PMID:
11286782.
Article
2. Karabudak R. Multipl skleroz: bilimsel araştırmalardan tedaviye-multipl sklerozda yeni yönelimler. Hacettepe Tıp Dergisi. 2008; 39:115–120.
3. Goldenberg MM. Multiple sclerosis review. P T. 2012; 37:175–184. PMID:
22605909.
4. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002; 159:1862–1868. PMID:
12411220.
Article
5. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004; 10:589–595. PMID:
15471378.
Article
6. Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol Assess. 2003; 7:iiiix–x. 1–111.
Article
7. Özakbaş S. Multipl Sklerozda Semptomatik Tedavi. Noro Psikiyatr Ars. 2011; 48:83–89.
8. Lance JW. Symposium synopsis. In : Feldman RG, Young RR, Koella KP, editors. Spasticity, Disordered Motor Control. Chicago, IL: Year Book Medical Publishers;1980. p. 17–24.
9. Richards RG, Sampson FC, Beard SM, Tappenden P. A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess. 2002; 6:1–73.
Article
10. Iodice R, Manganelli F, Dubbioso R. The therapeutic use of non-invasive brain stimulation in multiple sclerosis-a review. Restor Neurol Neurosci. 2017; 35:497–509. PMID:
28984619.
11. Mori F, Koch G, Foti C, Bernardi G, Centonze D. The use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of spasticity. Prog Brain Res. 2009; 175:429–439. PMID:
19660671.
Article
12. Palm U, Ayache SS, Padberg F, Lefaucheur JP. Non-invasive brain stimulation therapy in multiple sclerosis: a review of tDCS, rTMS and ECT results. Brain Stimul. 2014; 7:849–854. PMID:
25359259.
13. Centonze D, Koch G, Versace V, Mori F, Rossi S, Brusa L, et al. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis. Neurology. 2007; 68:1045–1050. PMID:
17389310.
Article
14. Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015; 126:1071–1107. PMID:
25797650.
Article
15. Centonze D, Petta F, Versace V, Rossi S, Torelli F, Prosperetti C, et al. Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis. Mult Scler. 2007; 13:269–271. PMID:
17439897.
Article
16. Ozakbas S, Cagiran I, Ormeci B, Idiman E. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J Neurol Sci. 2004; 218:3–7. PMID:
14759626.
Article
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33:1444–1452. PMID:
6685237.
Article
18. Patzold T, Schwengelbeck M, Ossege LM, Malin JP, Sindern E. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand. 2002; 105:164–168. PMID:
11886358.
Article
19. Heiskanen S, Meriläinen P, Pietilä AM. Health-related quality of life-testing the reliability of the MSQOL-54 instrument among MS patients. Scand J Caring Sci. 2007; 21:199–206. PMID:
17559438.
20. Read DJ, Matthews WB, Higson RH. The effect of spinal cord stimulation on function in patients with multiple sclerosis. Brain. 1980; 103:803–833. PMID:
7437891.
21. Hallett M. Transcranial magnetic stimulation and the human brain. Nature. 2000; 406:147–150. PMID:
10910346.
Article
22. Rossi S, Hallett M, Rossini PM, Pascual-Leone A;. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009; 120:2008–2039. PMID:
19833552.
Article
23. Siebner HR, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res. 2003; 148:1–16. PMID:
12478392.
Article
24. Nielsen JF, Sinkjaer T, Jakobsen J. Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study. Mult Scler. 1996; 2:227–232. PMID:
9050361.
Article
25. Kumru H, Murillo N, Samso JV, Valls-Sole J, Edwards D, Pelayo R, et al. Reduction of spasticity with repetitive transcranial magnetic stimulation in patients with spinal cord injury. Neurorehabil Neural Repair. 2010; 24:435–441. PMID:
20053952.
Article
26. Gupta M, Lal Rajak B, Bhatia D, Mukherjee A. Effect of r-TMS over standard therapy in decreasing muscle tone of spastic cerebral palsy patients. J Med Eng Technol. 2016; 40:210–216. PMID:
27010377.
Article
27. Málly J, Dinya E. Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS). Brain Res Bull. 2008; 76:388–395. PMID:
18502315.
Article
28. Mori F, Ljoka C, Magni E, Codecà C, Kusayanagi H, Monteleone F, et al. Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. J Neurol. 2011; 258:1281–1287. PMID:
21286740.
Article
29. Iodice R, Dubbioso R, Ruggiero L, Santoro L, Manganelli F. Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis. Restor Neurol Neurosci. 2015; 33:487–492. PMID:
26409407.
30. Nielsen JF, Klemar B, Hansen HJ, Sinkjaer T. A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1995; 58:254–255.
Article